🌟 Navbatagi lmiy safar 🇫🇮! Finlandiyaning Abo Akademi Universitetiga Professor Outi-Salo Achen taklifiga binoan bir oy davomida ilmiy safarga boraman. Ilg‘or Texnologiyalar Markazidagi "Inson va hayvonlarning patologik holatlari va kasalliklarining in silico imutatsion modellarini ishlab chiqish" nomli amaliy loyiha rahbari sifatida Abo Akademi olimlari – Dr. Phartiban Marimuthu va Prof. Outi Salo-Ahen bilan yaqin hamkorlik qilib kelmoqdaman. 🧪 Bu hamkorlik natijasida 6ta nufuzli jurnallarda qo‘shma maqolalar chop etildi. 📚 Safarda saraton, Parkinson, Altsgeymer va Xantington kabi nevrologik kasalliklarga qarshi samarali dori vositalarini bashorat qilish uchun dorilarni qayta yo'naltirish (Drug repurposing) texnikasidan foydalanib kompyuterda modellashtirish ishlarib olib boriladi. Avvalgi tadqiqotlarimizdan birida glioblastomaga qarshi FDA tomonidan tasdiqlangan 1379 dori ichidan eng samarali 4 tasini aniqlagan edik. Ushbu dorilarning ta’siri in-vitro tajribalarda ham o‘z tasdig‘ini topgan edi. Bu safar sarcoma va ko‘krak saratoni bo‘yicha tadqiqotlarga e’tibor qaratamiz.
🌟 Navbatagi lmiy safar 🇫🇮! Finlandiyaning Abo Akademi Universitetiga Professor Outi-Salo Achen taklifiga binoan bir oy davomida ilmiy safarga boraman. Ilg‘or Texnologiyalar Markazidagi "Inson va hayvonlarning patologik holatlari va kasalliklarining in silico imutatsion modellarini ishlab chiqish" nomli amaliy loyiha rahbari sifatida Abo Akademi olimlari – Dr. Phartiban Marimuthu va Prof. Outi Salo-Ahen bilan yaqin hamkorlik qilib kelmoqdaman. 🧪 Bu hamkorlik natijasida 6ta nufuzli jurnallarda qo‘shma maqolalar chop etildi. 📚 Safarda saraton, Parkinson, Altsgeymer va Xantington kabi nevrologik kasalliklarga qarshi samarali dori vositalarini bashorat qilish uchun dorilarni qayta yo'naltirish (Drug repurposing) texnikasidan foydalanib kompyuterda modellashtirish ishlarib olib boriladi. Avvalgi tadqiqotlarimizdan birida glioblastomaga qarshi FDA tomonidan tasdiqlangan 1379 dori ichidan eng samarali 4 tasini aniqlagan edik. Ushbu dorilarning ta’siri in-vitro tajribalarda ham o‘z tasdig‘ini topgan edi. Bu safar sarcoma va ko‘krak saratoni bo‘yicha tadqiqotlarga e’tibor qaratamiz.
BY Computer_simulations_Uz
Warning: Undefined variable $i in /var/www/tg-me/post.php on line 283
In general, many financial experts support their clients’ desire to buy cryptocurrency, but they don’t recommend it unless clients express interest. “The biggest concern for us is if someone wants to invest in crypto and the investment they choose doesn’t do well, and then all of a sudden they can’t send their kids to college,” says Ian Harvey, a certified financial planner (CFP) in New York City. “Then it wasn’t worth the risk.” The speculative nature of cryptocurrency leads some planners to recommend it for clients’ “side” investments. “Some call it a Vegas account,” says Scott Hammel, a CFP in Dallas. “Let’s keep this away from our real long-term perspective, make sure it doesn’t become too large a portion of your portfolio.” In a very real sense, Bitcoin is like a single stock, and advisors wouldn’t recommend putting a sizable part of your portfolio into any one company. At most, planners suggest putting no more than 1% to 10% into Bitcoin if you’re passionate about it. “If it was one stock, you would never allocate any significant portion of your portfolio to it,” Hammel says.
Among the actives, Ascendas REIT sank 0.64 percent, while CapitaLand Integrated Commercial Trust plummeted 1.42 percent, City Developments plunged 1.12 percent, Dairy Farm International tumbled 0.86 percent, DBS Group skidded 0.68 percent, Genting Singapore retreated 0.67 percent, Hongkong Land climbed 1.30 percent, Mapletree Commercial Trust lost 0.47 percent, Mapletree Logistics Trust tanked 0.95 percent, Oversea-Chinese Banking Corporation dropped 0.61 percent, SATS rose 0.24 percent, SembCorp Industries shed 0.54 percent, Singapore Airlines surrendered 0.79 percent, Singapore Exchange slid 0.30 percent, Singapore Press Holdings declined 1.03 percent, Singapore Technologies Engineering dipped 0.26 percent, SingTel advanced 0.81 percent, United Overseas Bank fell 0.39 percent, Wilmar International eased 0.24 percent, Yangzijiang Shipbuilding jumped 1.42 percent and Keppel Corp, Thai Beverage, CapitaLand and Comfort DelGro were unchanged.
